PTPA and neoplasm: Targeting PP2A as a therapeutic strategy has recently gathered much attention19,20, yet the complexity of cellular functions and pathways regulating PP2A has meant that the anti-tumour effects of activating19 or inhibiting20 PP2A activity remain poorly elucidated.